Viewing Study NCT01738594


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-25 @ 11:57 PM
Study NCT ID: NCT01738594
Status: TERMINATED
Last Update Posted: 2019-08-29
First Post: 2012-11-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Dose-Escalation Trial of Carfilzomib With and Without Romidepsin in Cutaneous T-Cell Lymphoma
Sponsor: Northwestern University
Organization: